Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

G Comi, P O'Connor, X Montalban, J Antel, E-W Radue, G Karlsson, H Pohlmann, S Aradhye, L Kappos, FTY720D2201 Study Group, Per Soelberg Sørensen, Jette Lautrup Battistini Frederiksen

131 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab